What is MaxCyte's change in other liabilities?

MaxCyte (MXCT) reported change in other liabilities of -$1K in Q1 2026.

How has MaxCyte's change in other liabilities changed year-over-year?

MaxCyte's change in other liabilities increased by 75.0% year-over-year, from -$4K to -$1K.

What is the long-term trend for MaxCyte's change in other liabilities?

Over 2 years (2021 to 2024), MaxCyte's change in other liabilities has grown at a -65.0% compound annual growth rate (CAGR), from -$73.5K to -$9K.

What does change in other liabilities mean?

Change in miscellaneous liabilities affecting operating cash flow.

MaxCyte MXCT Change in Other Liabilities

Change in Other Liabilities at other companies

Ginkgo BioworksDNA

-$758K—

RepligenRGEN

$1.27M+167%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's change in other liabilities?: MaxCyte (MXCT) reported change in other liabilities of -$1K in Q1 2026.
How has MaxCyte's change in other liabilities changed year-over-year?: MaxCyte's change in other liabilities increased by 75.0% year-over-year, from -$4K to -$1K.
What is the long-term trend for MaxCyte's change in other liabilities?: Over 2 years (2021 to 2024), MaxCyte's change in other liabilities has grown at a -65.0% compound annual growth rate (CAGR), from -$73.5K to -$9K.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.